Fierce JPM Week 2025: Full Schedule

Stephanie Butler is a Senior Conference Production Director with Fierce Life Sciences. Previously, Ms. Butler was a Division Manager at the American Conference Institute where she was responsible for the for the creation and development of legal and business conferences in the Pharmaceutical/Life... Read More →

Tuesday January 14, 2025 8:30am - 8:40am PST
Hyatt Regency San Francisco

8:40am PST

Industry Keynote

Tuesday January 14, 2025 8:40am - 9:00am PST

Hyatt Regency San Francisco

Tuesday January 14, 2025 8:40am - 9:00am PST
Hyatt Regency San Francisco

Keynote

9:00am PST

Accelerating Pharmaceutical Processing Innovation Through Artificial Intelligence

Tuesday January 14, 2025 9:00am - 9:20am PST

Hyatt Regency San Francisco

With innovation in new modalities driving increased complexity in the pharmaceutical pipeline, there is increasingly urgent need to deliver speed, quality, cost-efficiency and improved environmental footprint in pharmaceutical manufacturing. CDMOs are innovating across a number of areas to deliver this transformation – including by employing artificial intelligence, bringing tangible use cases to a promising technology.

In this session, Mike Riley, CEO of Veranova and David Shrier, CEO and Co-Founder of Phorum AI, will discuss a novel collaboration between their companies and will discuss how innovations in AI can unlock the potential of great scientific teams to create exponential improvements - 10x or even 100x - in the efficiency of how pharmaceuticals are produced.

Speakers

David Shrier

Co-Founder & CEO, Phorum.AI

David Shrier is a serial entrepreneur and globally renowned advisor on digital acceleration. He has extensive technology innovation experience, having led $11 billion of growth initiatives and taken a company public on the NYSE. He runs venture studio Visionary Future, where he has... Read More →

Mike Riley

CEO, Veranova

Mike Riley joined Veranova as Chief Executive Officer in May 2023. Mike has over 25 years of professional experience, the majority of which has been spent in the pharmaceutical contract development and manufacturing (CDMO) industry. Prior to joining Veranova, he spent 19 years at... Read More →

Tuesday January 14, 2025 9:00am - 9:20am PST
Hyatt Regency San Francisco

Keynote

9:20am PST

Panel: Pharma’s Financial Landscape: Revenue Trends, M&A Strategies, and Patent Expirations

Tuesday January 14, 2025 9:20am - 10:00am PST

Hyatt Regency San Francisco

With some of the industry’s top drugs moving toward patent cliffs later this decade, Big Pharma dealmakers have remained active despite economic uncertainties. The 2024 buyouts of Catalent, Alpine Immune Sciences and CymaBay Therapeutics—among others—showed that drugmakers were willing to strike deals for the right assets at the right prices. As the industry navigates the Inflation Reduction Act and other factors, biopharma leaders and venture capitalists on this panel will share their expectations for the year ahead.

Moderators

Fraiser Kansteiner

Staff Writer, Fierce Pharma

Fraiser Kansteiner is a staff writer at Fierce Pharma. He joined the Fierce team in 2020 and covers topics such as manufacturing, COVID-19 and drug delivery. He also manages Fierce Biotech and Fierce Pharma’s LinkedIn showcase pages. Before diving into pharma reporting, Fraiser... Read More →

Speakers

Adam Pearson

Chief Strategy Officer, Astellas

As Chief Strategy Officer of Astellas Pharma, Adam Pearson plays a pivotal role in shaping the company’s corporate strategy, spearheading initiatives in business planning, the development and execution of Primary Focus strategies, business partnerships, Rx+ business creation, Patient... Read More →

Tuesday January 14, 2025 9:20am - 10:00am PST
Hyatt Regency San Francisco

Panel

10:00am PST

Networking Break

Tuesday January 14, 2025 10:00am - 10:30am PST

Hyatt Regency San Francisco

Tuesday January 14, 2025 10:00am - 10:30am PST
Hyatt Regency San Francisco

Networking

10:30am PST

Executive Interview: Nelson Ambrogio, President of Radiology, Bayer Pharmaceuticals

Tuesday January 14, 2025 10:30am - 10:50am PST

Hyatt Regency San Francisco

Speakers

Nelson Ambrogio

President of Radiology, Bayer Pharmaceuticals

Nelson Ambrogio, President Radiology at Bayer, is a global healthcare leader with a career spanning more than 25 years with Bayer. Before joining Radiology in the beginning of 2024, he has been leading the Oncology Franchise for Bayer Pharmaceuticals in the United States, overseeing... Read More →

Tuesday January 14, 2025 10:30am - 10:50am PST
Hyatt Regency San Francisco

Executive Interview

10:50am PST

Presentation by Komodo Health

Tuesday January 14, 2025 10:50am - 11:10am PST

Hyatt Regency San Francisco

Tuesday January 14, 2025 10:50am - 11:10am PST
Hyatt Regency San Francisco

Presentation

11:10am PST

Panel: Global Clinical Trials: Overcoming Barriers and Seizing Opportunities in an International Landscape

Tuesday January 14, 2025 11:10am - 12:00pm PST

Hyatt Regency San Francisco

As clinical trials expand across borders, sponsors face unique challenges that can slow progress and increase complexity. This panel will dive into the key hurdles holding sponsors back, from navigating varying regulatory requirements to overcoming cultural and language barriers. Industry experts will explore strategies to streamline regulatory approvals, improve trial efficiency across diverse regions, and leverage cultural insights to enhance patient recruitment and retention. Join us for a deep dive into the opportunities and solutions driving the future of international clinical trials.

Moderators

Stephanie Butler

Senior Conference Production Director, Fierce Life Sciences

Speakers

Eric A. Hughes, MD, PhD

Executive Vice President of Global R&D, Chief Medical Officer, Teva Pharmaceuticals

Eric A. Hughes, MD, PhD, is Executive Vice President, Global R&D and Chief Medical Officer at Teva, overseeing a global organization responsible for the discovery, development, registration, medical affairs and patient safety activities for Teva’s generics, biosimilar and innovative... Read More →

Janet Hammond, M.D., PhD

Chief Development Officer, Atea Pharmaceuticals

Janet is an expert in virology with a proven track record in antiviral therapeutic drug discovery and development. Janet has more than 20 years of broad and deep pharmaceutical and biopharmaceutical experience including clinical development program leadership and responsibilities... Read More →

Tuesday January 14, 2025 11:10am - 12:00pm PST
Hyatt Regency San Francisco

Panel

12:00pm PST

Partner Presentation by SanaClis

Tuesday January 14, 2025 12:00pm - 12:20pm PST

Hyatt Regency San Francisco

Tuesday January 14, 2025 12:00pm - 12:20pm PST
Hyatt Regency San Francisco

Presentation

12:20pm PST

Networking Lunch

Tuesday January 14, 2025 12:20pm - 1:20pm PST

Hyatt Regency San Francisco

Tuesday January 14, 2025 12:20pm - 1:20pm PST
Hyatt Regency San Francisco

Networking

1:20pm PST

Panel: Our AI future: A Sector-by-Sector Breakdown

Tuesday January 14, 2025 1:20pm - 2:00pm PST

Hyatt Regency San Francisco

As AI and machine learning continue to reshape biotech, medtech, and pharma, this panel will explore the latest trends, challenges, and opportunities for AI-driven advancements across these sectors. Experts will take an in-depth look at how AI is streamlining processes—from drug discovery to medical device development—and share real-world examples of its impact on patient care.

Moderators

Zoey Becker

Staff Writer, Fierce Pharma

Zoey Becker is a staff writer for Fierce Pharma. She joined the Fierce team in 2022 after interning at the Cincinnati Herald. Zoey is a graduate of Miami University, where she earned a degree in journalism as well as sociology. She currently resides in Chicago with her two goldfi... Read More →

Speakers

Sai Jasti

Head of Data Science & Artificial Intelligence, Bayer Pharmaceuticals R&D

Sai Jasti is Head of Data Science and AI for Bayer Pharma R&D. In this capacity, Sai is responsible for driving Digital, Data and Analytics for Pharma R&D. He is passionate about helping scientists discover transformative medicines faster and driving innovation using Machine learning... Read More →

Dr. Maria Luisa Pineda

Envisagenics, CEO and Co-Founder

Dr. Maria Luisa Pineda is the CEO and co-founder of Envisagenics. Dr. Pineda embarked on her career in STEM as a high school Intel International Science Fair winner in Miami after immigrating from Colombia in 2001. She received her doctorate from Cold Spring Harbor Laboratory School... Read More →

Lars Fogh Iversen, PhD

Senior Vice President, Digital Science & Innovation, Novo Nordisk A/S

Lars has held his current role since early 2022 and is responsible for accelerating the digital transformation of R&ED and driving scientific innovation beyond the limits of human cognition through the purpose of DSI.A long-time employee of Novo Nordisk, Lars has held a variety of... Read More →

Tuesday January 14, 2025 1:20pm - 2:00pm PST
Hyatt Regency San Francisco

Panel

Qtag Featured

2:00pm PST

Partner Presentation by Phrma

Tuesday January 14, 2025 2:00pm - 2:20pm PST

Hyatt Regency San Francisco

Tuesday January 14, 2025 2:00pm - 2:20pm PST
Hyatt Regency San Francisco

Presentation

2:20pm PST

Executive Interview

Tuesday January 14, 2025 2:20pm - 2:40pm PST

Hyatt Regency San Francisco

Tuesday January 14, 2025 2:20pm - 2:40pm PST
Hyatt Regency San Francisco

Executive Interview

2:40pm PST

Networking Break

Tuesday January 14, 2025 2:40pm - 3:10pm PST

Hyatt Regency San Francisco

Tuesday January 14, 2025 2:40pm - 3:10pm PST
Hyatt Regency San Francisco

Networking

3:10pm PST

Executive Interview

Tuesday January 14, 2025 3:10pm - 3:30pm PST

Hyatt Regency San Francisco

Tuesday January 14, 2025 3:10pm - 3:30pm PST
Hyatt Regency San Francisco

Executive Interview

3:30pm PST

Partner Presentation by Walgreens

Tuesday January 14, 2025 3:30pm - 3:50pm PST

Hyatt Regency San Francisco

Tuesday January 14, 2025 3:30pm - 3:50pm PST
Hyatt Regency San Francisco

Presentation

3:50pm PST

The Future of Oncology: Key Investment Areas and Advancements in Treatment Methodologies

Tuesday January 14, 2025 3:50pm - 4:30pm PST

Hyatt Regency San Francisco

ADCs, bispecifics and radiopharmaceuticals are making waves in oncology treatment. Practice-changing clinical data have spurred major investments and deals. At the same time, much-touted cell therapies have run into real-world issues such as capacity and infrastructure limitations. During this panel, we will explore what’s next for these trends as the industry continues its efforts to advance patient care.

Moderators

Angus Liu

Deputy Editor, Fierce Pharma

Angus is a deputy editor with Fierce Pharma. He earned his Master’s at Northwestern University’s Medill School of Journalism, where he worked as a health reporter besides learning pertinent skills in magazine editing and interactive production. Prior to Medill, he worked as a... Read More →

Speakers

Teresa Bitetti

President of the Global Oncology Business Unit and a member of the Executive Team, Takeda

Teresa Bitetti is President of the Global Oncology Business Unit and a member of the Executive Team at Takeda, where she oversees a global portfolio of therapies targeting gastrointestinal, thoracic, and hematological cancers. In this role, Teresa leads all aspects of Takeda’s multi-billion-dollar... Read More →

Hesham Abdullah

Senior Vice President, Global Head Oncology, Research & Development, GSK

Hesham Abdullah is a seasoned physician-scientist who uniquely combines a clinician’s understanding of the impact cancer has on patients with deep expertise in identifying transformational opportunities to improve cancer treatment and care.As the head of GSK’s global oncology... Read More →

Puja Sapra

Senior Vice President, Biologics Engineering & Oncology Targeted Delivery, AstraZeneca

I serve as Vice President, Tumour Targeted Delivery, Early Oncology. In my current role, I lead the research group dedicated to the discovery and preclinical development of targeted cancer therapeutics and novel delivery mechanisms that selectively attack cancer cells while sparing... Read More →

Mai-Britt Zocca, Ph.D.

Founder and Chief Executive Officer, IO Biotech

Dr. Zocca brings more than 20 years of experience in the biotechnology field and has founded and co-founded several biotech spinouts. Her focus on translational and clinical immune oncology has led to the development of important investigational immunotherapies for a variety of cancer... Read More →

Bassil I. Dahiyat, Ph.D.

President & Chief Executive Officer, Xencor

Bassil Dahiyat has been Xencor’s president and chief executive officer since the Company’s incorporation in August 1997. He is the co-founder of Xencor and co-inventor of Xencor’s breakthrough XmAb® technology. He has led the Company in creating a diverse clinical-stage portfolio... Read More →

Tuesday January 14, 2025 3:50pm - 4:30pm PST
Hyatt Regency San Francisco

Panel